Updated:
Labcorp
Labcorp runs global diagnostics and drug development labs for over 60,000 employees, with an AI-powered data platform for Alzheimer's research.
Labcorp
Labcorp operates as a global life sciences company with over 60,000 employees. It was founded in 1971, though the current corporate entity derives from the merger of National Health Laboratories and Roche Biomedical Laboratories in 1995. The firm runs diagnostic labs, central labs for clinical trials, and nonclinical labs across North America, Europe, Asia, and Australia. Labcorp supports drug development across multiple asset classes: diagnostics (routine and specialty), central lab services for biopharma, nonclinical testing, and data analytics. Its AI-powered real-world data platform for Alzheimer's disease was developed alongside AWS and Datavant (per the firm, 2024). Portfolio holdings include Invitae (genetic testing), and it operates Labcorp OnDemand for direct-to-consumer lab tests. Geographically, it reaches over 95% of the U.S. population and runs labs in Europe, Asia, and Australia. The company has roughly 1,200 PhDs and MDs on staff. It maintains a corporate foundation that works on healthcare access. Recent activity includes the acquisition of Invitae's genetic testing business in 2023 (per the firm, 2023). Labcorp's structure is distinct as a publicly traded company (NYSE: LH) with a parallel family-office wealth vehicle, Laboratory Corporation of America Holdings, a holding company that owns the Labcorp operating entity. This architecture separates the day-to-day diagnostics business from a investment portfolio, though public filings detail no separate family-office AUM.
General information
Firm type
Single Family Office
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Burlington
Corporate office
Burlington, NC, United States
Sector focus
Frequently asked questions
How does Labcorp generate proprietary deal flow?
Labcorp owns the largest clinical lab network in the US, giving it access to patient data and physician relationships. It uses its lab data to identify drug development trends and partner with biopharma companies, often leading to direct investments or co-development deals.
Is Labcorp a single family office or a public company?
Labcorp is a publicly traded company (NYSE: LH) with a holding company structure that may serve wealth-management purposes for its founding family. However, no separate family-office AUM is publicly disclosed.
What investment stages does Labcorp target?
It does not typically make direct equity investments beyond corporate venture. The Labcorp Venture Fund focuses on early-stage diagnostics and life sciences companies, though specific deal data is limited.
Does Labcorp participate in fund commitments?
There is no public disclosure of Labcorp committing capital to external funds. It likely manages its excess cash through public securities and corporate treasury instruments.
What sectors does Labcorp explicitly avoid?
Labcorp does not publish a formal list of excluded sectors. The firm's focus is on diagnostics, drug development, and life sciences assets.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: